Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/26/2012 | EP2536410A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
12/26/2012 | EP2536409A1 Nicotine-containing soft gelatin pastilles |
12/26/2012 | EP2536408A1 Efflux pump inhibitors |
12/26/2012 | EP2536407A2 Taxane pro-emulsion formulations and methods making and using the same |
12/26/2012 | EP2536405A1 Non peptidic 14-3-3 inhibitors and the use thereof |
12/26/2012 | EP2536404A1 Compounds for the treatment of renal cell carcinoma |
12/26/2012 | EP2536403A1 Compositions comprising perfluorooctanoic acid |
12/26/2012 | EP2536402A1 Compositions comprising amphetamin and lisdexamfetamine |
12/26/2012 | EP2536401A1 Doxylamine resinate complex |
12/26/2012 | EP2536400A1 Pharmaceutical comprising myramistin |
12/26/2012 | EP2536399A1 Method for activation and conjugation of biomolecules |
12/26/2012 | EP2536398A1 Treatment of osteoporosis |
12/26/2012 | EP2536396A2 Process for the preparation of oral solid dosage forms comprising valsartan |
12/26/2012 | EP2536394A2 Stabilized phenylcarbamate derivative in solid state |
12/26/2012 | EP2536301A1 Oral smokeless tobacco products and oral smokeless non-tobacco snuff products comprising carbamide or carbamide salts. |
12/26/2012 | EP2536293A1 Methods and compositions for use in aquaculture |
12/26/2012 | EP2536288A1 A novel boswellia low polar gum resin extract and its synergistic compositions |
12/26/2012 | EP2536286A1 Inhibitors and methods of inhibiting bacterial and viral pathogens |
12/26/2012 | EP2536285A1 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
12/26/2012 | EP2536283A1 Phenyl-heteroaryl derivatives and methods of use thereof |
12/26/2012 | EP2536282A1 Methods for treating infection |
12/26/2012 | EP2536279A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate |
12/26/2012 | EP2536276A1 Novel bexarotene analogs |
12/26/2012 | EP2453017A9 Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases |
12/26/2012 | CN202620280U Novel capsule filled with perindopril solid preparation and indapamide solid preparation |
12/26/2012 | CN202620274U Secnidazole tablet |
12/26/2012 | CN202620272U Diclofenac sodium sustained-release pellet |
12/26/2012 | CN1988898B Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
12/26/2012 | CN1826333B Diamine derivatives |
12/26/2012 | CN1816536B Regulator of cannabinoid receptor |
12/26/2012 | CN102844436A Aptamer for ngf and use thereof |
12/26/2012 | CN102844435A Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
12/26/2012 | CN102844431A Diacylglycerole acyltranferase gene, and use thereof |
12/26/2012 | CN102844386A Use of physiological cooling active ingredients, and agents containing such active ingredients |
12/26/2012 | CN102844325A Preparation of polypeptides and salts thereof |
12/26/2012 | CN102844324A Methods for producing amino-substituted glycolipid compounds |
12/26/2012 | CN102844323A Cdk5 inhibitors and therapeutic uses thereof |
12/26/2012 | CN102844320A 杂环化合物 Heterocyclic Compounds |
12/26/2012 | CN102844318A Compounds for treating respiratory syncytial virus infections |
12/26/2012 | CN102844317A Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
12/26/2012 | CN102844316A Azacyclic spiroderivatives as hsl inhibitors |
12/26/2012 | CN102844315A Crystalline salts of a potent hcv inhibitor |
12/26/2012 | CN102844313A Compositions and methods for enhancing proteasome activity |
12/26/2012 | CN102844309A Processes for the preparation of rivaroxaban and intermediates thereof |
12/26/2012 | CN102844307A Triazole compounds as ksp inhibitors |
12/26/2012 | CN102844305A Antibacterial isoquinolin-3-ylurea derivatives |
12/26/2012 | CN102844301A Novel benzamide derivatives |
12/26/2012 | CN102844300A Cyclic keto-enols for therapy |
12/26/2012 | CN102844299A Pesticidal arylpyrrolidines |
12/26/2012 | CN102844294A Crystalline ingenol mebutate |
12/26/2012 | CN102844290A 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis |
12/26/2012 | CN102844077A A solid pharmaceutical composition for neutralizing stomach acid |
12/26/2012 | CN102844049A Combination therapy of an afucosylated cd20 antibody with a mtor inhibitor |
12/26/2012 | CN102844048A Pharmaceutical agent for treatment and/or prevention of cancer |
12/26/2012 | CN102844047A Immunogenic compositions including tlr activity modulators |
12/26/2012 | CN102844035A Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
12/26/2012 | CN102844034A Composition containing stabilized phosphatidylserine |
12/26/2012 | CN102844033A Methods and compositions for improving implant osseointegration |
12/26/2012 | CN102844032A Compound for treatment of respiratory condition or disease |
12/26/2012 | CN102844031A Organic compound for use in the treatment of liver cancer |
12/26/2012 | CN102844030A Therapies for treating hepatitis c virus infection |
12/26/2012 | CN102844029A Beta-carbolines for use in the treatment of hearing loss and vertigo |
12/26/2012 | CN102844028A Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside |
12/26/2012 | CN102844027A Novel therapeutic methods for treating inflammation and immune system disorders |
12/26/2012 | CN102844026A Fungal nail treatment composition |
12/26/2012 | CN102844025A Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis |
12/26/2012 | CN102844024A Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment |
12/26/2012 | CN102844023A Cdc7 kinase inhibitors and uses thereof |
12/26/2012 | CN102844022A Local anesthetic emulsion compositions and methods of making and using the same |
12/26/2012 | CN102843921A Methods and lipid compositions for promoting development of gut flora |
12/26/2012 | CN102839206A Preparation method for promoting self generation of human bone marrow hematopoietic stem cells |
12/26/2012 | CN102839181A Nucleic acid aptamer sequence of gastric cancer cells, and uses thereof |
12/26/2012 | CN102838969A Ice slush and preparation method thereof |
12/26/2012 | CN102838685A Wintergreen pure polysaccharide LTC-0-1 and application thereof |
12/26/2012 | CN102838652A Oleanolic acid derivative with function of resisting malignant tumor, as well as preparation method and applications of oleanolic acid derivative |
12/26/2012 | CN102838651A Oleanolic acid derivatives, and preparation method and application thereof |
12/26/2012 | CN102838645A Polyphenol hydroxy flavone compound with pharmaceutical function and preparation method thereof |
12/26/2012 | CN102838625A Tetrahydropyridothiazole compounds, preparation method, drug compositions containing the same, and uses thereof |
12/26/2012 | CN102838623A Cefminox sodium compound crystal, preparation method of cefminox sodium compound crystal and sterile powder injection containing cefminox sodium compound crystal |
12/26/2012 | CN102838621A (6R,7R)-3-methyl-7-[alpha-(N,N'-diisopropyl amidine thio)-acetylamino]-8-oxo-5-thia-1-azabicyclo[4,2,0]-oct-2-alkene-2-formic betaine crystals |
12/26/2012 | CN102838618A Method for preparing prasugrel, and prasugrel hydrochloride novel crystal forms |
12/26/2012 | CN102838617A Polymorph and pharmaceutical composition of (S)-2-(2- nicotinoyloxyjatropha-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-yl)-2-(2-chlorphenyl)-methyl acetate |
12/26/2012 | CN102838607A Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
12/26/2012 | CN102838605A Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes |
12/26/2012 | CN102838601A Selective phosphatidylinositol-3 kinase delta inhibitor |
12/26/2012 | CN102838600A Phenylquinazoline PI3Kdelta inhibitors |
12/26/2012 | CN102838599A Polymorphs |
12/26/2012 | CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof |
12/26/2012 | CN102838592A 2,4-diaryl thiazole derivative, and pharmaceutical composition, preparation method and application thereof |
12/26/2012 | CN102838590A Amino quinazoline derivative and application thereof in preparation of antineoplastic drugs |
12/26/2012 | CN102838588A Oral thrombin inhibitors, preparation methods and medical uses thereof |
12/26/2012 | CN102838571A Andrographolide derivative containing gamma-subunit butenolide, synthetic method and application thereof |
12/26/2012 | CN102838570A Mailuoning ester and preparation method and function thereof |
12/26/2012 | CN102838567A Benzenesulfonyl piperazine compounds or benzoyl piperazine compounds, preparation methods and uses thereof |
12/26/2012 | CN102838550A Quinolinylcrotyl compound and its application in preparation of anti-malignant tumor drugs |
12/26/2012 | CN102838549A New class of 1,5,6-substituted pyrimidine derivatives with anti-HIV virus effects |
12/26/2012 | CN102838546A Pyrazole derivatives as modulators of 5-ht2a serotonin receptor useful for treatment of disorders related thereto |
12/26/2012 | CN102838545A Crystalline form IV of celecoxib, preparation method and purpose thereof |
12/26/2012 | CN102838544A Crystalline form II of celecoxib, preparation method and purpose thereof |
12/26/2012 | CN102838543A Crystalline form III of celecoxib, preparation method and purpose thereof |